Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07739368) titled 'Safety and Efficacy Study of Ferric Maltol To Treat Iron Deficiency Anaemia in Chinese Patients With Inflammatory Bowel Disease' on July 22.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Jiangsu Aosaikang Pharmaceutical Co., Ltd.

Condition: Iron Deficiency Anaemia

Intervention: Drug: Ferric Maltol

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: September 1, 2021

Target Sample Size: 122

Countr...